Inventor · disambiguated record
Gert Bolt
Also filed as: BOLT GERT
6 granted patents·14 pending applications·4 citations·filing 2005–2018
73Inventor score
Files withNOVO NORDISK AS13NOVO NORDISK HEALTHCARE AG3BOLT GERT2JOHNSEN LAUST BRUUN1NOVA NORDISK AS1
Top patents by PatentIndex Score
20 records- 0170US9150848B2Conjugated factor VIII moleculesNOVO NORDISK AS·Filed 2014·Granted Oct 6, 2015·1 cites·12 claims
- 0269US8536126B2Conjugated factor VIII moleculesNOVO NORDISK AS·Filed 2013·Granted Sep 17, 2013·1 cites·7 claims
- 0367US9493543B2Factor VIII fusion proteinBOLT GERT·Filed 2011·Granted Nov 15, 2016·2 cites·19 claims
- 0460US2011118183A1N-glycosylated human growth hormone with prolonged circulatory half-lifeNOVO NORDISK HEALTHCARE AG·Filed 2009·Application pending·0 cites
- 0557US9125890B2Compounds suitable for treatment of haemophiliaNOVO NORDISK AS·Filed 2013·Granted Sep 8, 2015·0 cites·20 claims
- 0657US2013189239A1Conjugated Factor VIII MoleculesBOLT GERT·Filed 2009·Application pending·0 cites
- 0756US2018179262A1Compounds Suitable for Treatment of HaemophiliaNOVO NORDISK AS·Filed 2018·Application pending·0 cites
- 0855US2011137011A1Hyperglycosylated human coagulation factor ixNOVO NORDISK AS·Filed 2009·Application pending·0 cites
- 0955US2017020992A1Factor VIII Molecules with Reduced VWF BindingNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1053US2015080309A1Compounds Suitable for Treatment of HaemophiliaNOVA NORDISK AS·Filed 2013·Application pending·0 cites
- 1151US8871714B2Hyperglycosylated human coagulation factor IXNOVO NORDISK AS·Filed 2012·Granted Oct 28, 2014·0 cites·4 claims
- 1249US2016222086A1Conjugated Factor VIII MoleculesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 1347US2015045303A1Pharmaceutical Composition Suitable for Treatment of HaemophiliaNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 1446US2016318991A1Compounds Suitable for Treatment of HaemophiliaNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1544US2017015729A1Factor VIII Fusion ProteinNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1642US2016207977A1Compounds Suitable for Treatment of HaemophiliaNOVO NORDISK AS·Filed 2014·Application pending·0 cites
- 1741US9982033B2Factor VIII polypeptide titers in cell culturesJOHNSEN LAUST BRUUN·Filed 2008·Granted May 29, 2018·0 cites·22 claims
- 1837US2008058255A1Glycosylation-Disrupted Factor VII VariantsNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 1934US2008227691A1Blood Coagulation FVIII AnaloguesNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 2033US2016120954A1Pharmaceutical Composition Suitable for Treatment of HaemophiliaNOVO NORDISK AS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gert Bolt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →